Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Exiqon, a provider of products for gene expression analysis has launched new products for the research and development of RNA targeted medicine.
Subscribe to our email newsletter
The drugs include LNA tm as the active pharmaceutical ingredient.
The new products include oxy-LNA tm amidites in kilogram quantities, LNA tm oligonucleotides in gram quantities, miRCURY LNA tm microRNA Inhibitors in gram quantities
Exiqon will also offer non-exclusive, manufacturing licenses to customers to manufacture oxy-LNA tm amidites for their research programs.
The company however does not grant licenses to the manufacturing, research, development or sale of LNA tm based drugs for clinical trials.